Privi Speciality Chemicals Limited — Board Meeting, 19-12-2025: Outcome of Board Meeting
19-12-2025 | 07:21 pm
19-12-2025 | 07:21 pm
Privi Speciality Chemicals' Board approved the merger of Privi Fine Sciences & wholly-owned subsidiary Privi Biotechnologies into itself. This strategic move aims to boost operations, expand offerings, and cut costs. PFSPL shareholders get 1 PSCL share for every 135 PFSPL shares. #Merger #PSCL
No comments yet. Be the first to comment!
